In addition to serum, exosomal levels of S100A4, NNMT, CD44v6/C1QBP, DYRK1A, BMI1, and Eps8 derived from tumor tissues are also elevated in highly-metastatic HCC, GC, and PC patients [74–79]. The gene discussed is S100A4; the disease is hepatocellular carcinoma.